RethinkPeptides
ArticlesTopicsResearch

MK-677 (Ibutamoren)

3 articles in this topic.

MK-677 (Ibutamoren)

Why MK-677 Isn't a Peptide (But Gets Grouped with Them)

MK-677 (ibutamoren) is a small molecule, not a peptide. It mimics ghrelin at the same receptor that GHRPs target. Here's why the distinction matters.

13 min read|Mar 26, 2026
MK-677 (Ibutamoren)

MK-677 Side Effects: What the Clinical Data Shows

MK-677 ibutamoren side effects from clinical trials: water retention, insulin resistance, hunger, and long-term safety data from the Nass and Svensson studies.

14 min read|Mar 22, 2026
MK-677 (Ibutamoren)

MK-677 and Sleep: Deep Sleep and REM Effects

MK-677 (ibutamoren) increased stage IV deep sleep by 50% and REM sleep by 20-50% in clinical studies. Full review of the sleep architecture data.

13 min read|Mar 22, 2026

RethinkPeptides

Evidence-based peptide education. No hype, no sales. Just science.

Navigate

All ArticlesTopicsResearch DatabaseEvidence MethodologyDownload DataSearch

About

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of Use

Disclaimer

Content on RethinkPeptides is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. Peptides discussed here may not be approved for human use in your jurisdiction.

© 2026 RethinkPeptides. All rights reserved.